Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marvao Medical Devices Ltd.

Hemodialysis catheter reduces risk of bloodstream infections

This article was originally published in Start Up

Executive Summary

Catheter-related bloodstream infections are the bane of tunneled dialysis catheters, despite the widespread use of antimicrobial dressings or an injection cap placed on the exit site of the catheter to help protect the inside of the catheter from becoming colonized. The NexSite Hemodialysis Catheter from Marvao Medical Devices Ltd. is designed to reduce these bloodstream infections with a protective biomaterial tissue ingrowth scaffold that is part of the catheter and positioned at the skin exit site.

You may also be interested in...



What’s Next? Five Things To Look Out For In December

Generics Bulletin previews the most noteworthy and anticipated events for December 2023.

Member States Want Action Over High-Risk IVDs and Eudamed Medical Device Database

After some 10 years of the implementation of the EU’s Medical Device and IVD Regulations being an annual agenda item at December Council of the EU meetings, the scale of problems remains the same.

Transformative Innovation: How India Can Up Its Game, Big Pharma GCCs Add Value

A new report discusses the priorities that India should focus on to leapfrog towards transformative innovation. Big pharma’s expanding global capability centres (GCCs) in India are also contributing to the innovation ecosystem while positioning the country as the global industry's “backbone”.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT037977

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel